Brief: Oryzon Says Investor To Convert Bonds For Nominal Amount Of 270,000 Euros
July 22 (Reuters) - Oryzon Genomics ORY.MC :
* SAID ON FRIDAY THE INVESTOR NICE&GREEN HAD APPLIED FOR
CONVERSION OF BONDS FOR A NOMINAL AMOUNT OF 270,000 EUROS AT A
CONVERSION PRICE AT 1.71 EUROS PER SHARE, REPRESENTING 158,181
NEW SHARES WITH A PAR VALUE OF 0.05 EUROS EACH
Source text: https://tinyurl.com/ym2a8nha
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28